Exicure, Inc.
Key Metrics
Market Snapshot
About
Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics based on its proprietary spherical nucleic acid (SNA) technology platform. The company's SNA constructs are designed to penetrate cells and tissues more effectively than traditional nucleic acid therapies, with applications in immuno-oncology, inflammatory diseases, and genetic disorders. Exicure is advancing multiple programs leveraging its novel nucleic acid architecture.